Table 2. Clinical characteristics and CM values in hospitalized patients with COVID-19, depending on baseline HbА1c and DM history.
| Parameters | Patients w/o DM history | Patients with known DM Group C (n = 46) |
Kruskal Wallis test, Mann-Whitney test, p-value |
|
|---|---|---|---|---|
| HbA1c ≤ 6,0% Group A (n = 80) |
HbA1c ≥ 6,0% Group B (n = 68) |
|||
| HbA1c at admission, % | 5,7 [5,3; 5,8] | 6,4[6,2; 6,6] | 7,7 [7,2; 8,9] |
<0,001 p1-2 = 0,003 p1-3<0,001 p2-3 = 0,002 |
| Gender, no. of patients (%) M/F | 46/25 65%/35% |
34/44 43,5%/56,5% |
17/29 37%/63% |
0,019 |
| Age, y | 50 [41;59] | 60,5 [52;74,5] | 62 [54;70] |
<0,001 p1-2 = 0,003 p1-3 = 0,002 p2-3 = 0,126 |
| BMI kg/m2 | 27,3 [24,6;30,5] | 29,8[25;33,9] | 30,9 [28,58;36,36] | 0,087 |
| Hemoglobin, g/L | 143[132,2;149,7] | 132[123;143,7] | 133,5 [126,5;145,5] | 0,113 |
| GFR by EPI, mL/min/1,73m2 |
83,2[69,0;102,5] | 75,8[56,6;96,7] | 74,17[49,7;90,7] | 0,231 |
| FPG, mmol/L | 5,03[4,9;5,33] | 5,33[5,0;5,9] | 8,2[7,0;10,6] |
<0,001 p1-2 = 0,131 p1-3<0,001 p2-3<0,001 |
| ABG, mmol/L | 5,78[5,39;6,3] | 6,39[5,85;7,02] | 10,34[7,47;12,84] |
<0,001 p1-2 = 0,076 p1-3<0,001 p2-3 <0,001 |
| eAG, mmol/L | 6,49[6,21;6,65] | 7,61[7,29;7,76] | 9,68[8,92;11,63] |
<0,05 p1-2 = 0,064 p1-3 = 0,004 p2-3 = 0,016 |
The data is presented as median value (Ме) and interquartile range [25; 75] or mass percentage (%).
HbA1c, glycated hemoglobin; BMI, body mass index; GFR, glomerular filtration rate; FPG, fasting plasma glucose, mmol/L; 24hMPG, 24-hour mean plasma glucose over the last three months; SIH, stress-induced hyperglycemia, mmol/L; ABG, admission blood glucose, mmol/L.